...
首页> 外文期刊>Annals of epidemiology >The discipline of epidemiology: engaging in the full breadth of population health science
【24h】

The discipline of epidemiology: engaging in the full breadth of population health science

机译:流行病学的学科:从事人口健康科学的完整广度

获取原文
获取原文并翻译 | 示例
           

摘要

This address was delivered by Harold I. Feldman, MD, MSCE, at the Annual Meeting of the American College of Epidemiology in New Orleans, Louisiana, on September 26, 2017. Dr. Feldman is George S. Pepper Professor of Public Health and Preventive Medicine, Professor of Epidemiology and Medicine, and Chair, Department of Biostatistics, Epidemiology, and Informatics at the Perelman School of Medicine at the University of Pennsylvania. He is recognized nationally and internationally for his expertise in kidney disease epidemiology. Dr. Feldman pioneered the integration of epidemiology and renal medicine with his first studies of dialyzer reuse and hemodialysis vascular access morbidity. He is internationally renowned in nephrology and clinical epidemiology and an architect of one of the largest and most successful epidemiological research programs in chronic kidney disease. For over 15 years, he has led NIH's Chronic Renal Insufficiency Cohort Study, placing him at the helm of the "Framingham Study of Renal Disease". It has elucidated the chronic kidney disease specific relationships of mineral dysmetabolism and cardiovascular complications; dietary sodium and heart failure; novel vascular stiffness metrics and renal disease progression; cardiovascular biomarkers and heart failure; and cognitive decline and renal dysfunction, among others. He has also led the nation's largest trials targeting hemodialysis vascular access morbidity, discovered the benefits of transplantation before dialysis dependence, elucidated racial disparities and the role of genetics in kidney failure, and shaped our understanding of the toxicity from unregulated reuse of medical devices. He is the past President of the American College of Epidemiology and directs one of the nation's largest clinical epidemiology and biostatistics programs. Dr. Feldman has an MD from Boston University and an MSCE from the University of Pennsylvania. He is an elected member of the American Society of Clinical Investigation, the Association of American Physicians, and the American Epidemiological Society. (C) 2018 Elsevier Inc. All rights reserved.
机译:该地址由MSCE,MSCE,MSCE,MSCE在2017年9月26日的新奥尔良,MSCE的年会。医学,流行病学和医学教授,以及宾夕法尼亚大学Perelman医学院的生物统计学,流行病学和信息学系。他在全国和国际上认识到他对肾病流行病学的专业知识。比尔德曼博士与他对透析仪再利用和血液透析血管进入发病率的第一次研究进行了流行病学和肾药的整合。他在肾脏学和临床流行病学中国际知名,以及慢性肾病中最大,最成功的流行病学研究计划之一的建筑师。超过15年,他领导了NIH的慢性肾功能不全的队列研究,将他放在掌舵“肾病的纹章疾病”的掌舵处。它阐明了慢性肾脏疾病的矿物质发育蛋白和心血管并发症的特异性关系;膳食钠和心力衰竭;新型血管僵硬度量和肾病进展;心血管生物标志物和心力衰竭;和认知的下降和肾功能不全,等等。他还领导了全国最大的试验,靶向血液透析血管接入发病率,发现透析依赖性前移植的好处,阐明了种族差异和遗传学在肾功能衰竭中的作用,并形成了对医疗设备的无管制重用的毒性的理解。他是美国流行病学学院的过去的主席,并指导了全国最大的临床流行病学和生物统计学计划之一。 Feldman博士从波士顿大学和宾夕法尼亚大学的MSCE有一个MD。 He is an elected member of the American Society of Clinical Investigation, the Association of American Physicians, and the American Epidemiological Society. (c)2018年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号